USTR Announces Section 301 Exclusions Extension, Seeks Comments

Posted by Kelsay Calvaruso on 2/14/23 5:00 PM

On February 2, 2023, in a notice, the Office of the U.S. Trade Representative (USTR) announced a 75-day interim extension for 81 medical-care product exclusions related to the COVID-19 pandemic. The extension is to allow for the review of comments requested in the same notice on whether these exclusions should be extended for up to six months. According to the notice, the exclusions will be evaluated on a case-by-case basis.

Comments are due March 7, 2023.

Details on comment submission can be found in the notice here:

Topics: China, USTR, Exclusions, COVID-19, Trade Remedies

Expeditors' Newsflash articles are compiled from a number of public sources that, to the best of Expeditors' knowledge, are true and correct. It is our intent to present only accurate information. However, in the event any information contained herein is erroneous, Expeditors International of  Washington, Inc. accepts no liability or responsibility.                                                                                           

Copyright © Expeditors International of Washington, Inc.  Expeditors' Newsflash articles may not be reproduced in any form without advanced written consent of an authorized officer of the copyright holder.     

Recommended for you